WO2026003142A1 - Process - Google Patents

Process

Info

Publication number
WO2026003142A1
WO2026003142A1 PCT/EP2025/068016 EP2025068016W WO2026003142A1 WO 2026003142 A1 WO2026003142 A1 WO 2026003142A1 EP 2025068016 W EP2025068016 W EP 2025068016W WO 2026003142 A1 WO2026003142 A1 WO 2026003142A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
group
alkyl group
metal
catalyst
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/EP2025/068016
Other languages
French (fr)
Inventor
Nathalie JOSET
Martin Alan LOVCHIK
Fridtjof Schroeder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan SA
Original Assignee
Givaudan SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan SA filed Critical Givaudan SA
Publication of WO2026003142A1 publication Critical patent/WO2026003142A1/en
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2204Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/2208Oxygen, e.g. acetylacetonates
    • B01J31/2217At least one oxygen and one nitrogen atom present as complexing atoms in an at least bidentate or bridging ligand
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/70Oxidation reactions, e.g. epoxidation, (di)hydroxylation, dehydrogenation and analogues
    • B01J2231/72Epoxidation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2523/00Constitutive chemical elements of heterogeneous catalysts
    • B01J2523/50Constitutive chemical elements of heterogeneous catalysts of Group V (VA or VB) of the Periodic Table
    • B01J2523/55Vanadium
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2523/00Constitutive chemical elements of heterogeneous catalysts
    • B01J2523/70Constitutive chemical elements of heterogeneous catalysts of Group VII (VIIB) of the Periodic Table
    • B01J2523/72Manganese
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0238Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P
    • B01J2531/0241Rigid ligands, e.g. extended sp2-carbon frameworks or geminal di- or trisubstitution
    • B01J2531/0252Salen ligands or analogues, e.g. derived from ethylenediamine and salicylaldehyde

Definitions

  • the present invention relates to improved catalysts for selective epoxidation and to improved methods for making intermediates in the production of fragrances such as Amberketal and Amberketal homologues by epoxidation starting from [3-farnesene.
  • Amberketal provides a powerful and tenacious ambery and woody odour that is useful in fragrance compositions alone or in combination with other woody or ambery ingredients.
  • Amberketal is traditionally prepared from Manool via a number of chemical transformations. However, the supply of natural Manool is limited. It is therefore desirable to provide a new efficient and cost effective synthetic route to obtain Amberketal and Amberketal homologues.
  • R 3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group; m is selected from 0 to 4.
  • a catalyst of formula (X) comprising a metal M complexed with a salen ligand wherein each R 1 is independently hydrogen, an alkyl group, an aryl group, or both R 1 together with the carbon atoms to which R 1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R 2 is independently hydrogen or an alkyl group, or both R 2 together with the carbon atoms to which R 2 are attached form a cycloalkylene group or an arylene group;
  • R 4 is selected from tert-butyl and tert-pentyl; m is selected from 0 to 4; the metal M is selected from the group consisting of Mn and V; and
  • Y is selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide.
  • Formula (II) Formula (III) wherein the method comprises contacting a compound of Formula (IV) with a catalyst comprising a metal M complexed with a salen ligand of formula (I) wherein each R 1 is independently hydrogen, an alkyl group, an aryl group, or both R 1 together with the carbon atoms to which R 1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R 2 is independently hydrogen or an alkyl group, or both R 2 together with the carbon atoms to which R 2 are attached form a cycloalkylene group or an arylene group;
  • R 3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group; m is selected from 0 to 4;
  • Formula (II) Formula (III) wherein the method comprises contacting a compound of Formula (IV) with a catalyst of formula (X) comprising a metal M complexed with a salen ligand wherein each R 1 is independently hydrogen, an alkyl group, an aryl group, or both R 1 together with the carbon atoms to which R 1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R 2 is independently hydrogen or an alkyl group, or both R 2 together with the carbon atoms to which R 2 are attached form a cycloalkylene group or an arylene group;
  • R 3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group;
  • R 4 is selected from tert-butyl and tert-pentyl; m is selected from 0 to 4; the metal M is selected from the group consisting of Mn and V; and
  • Y is selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide.
  • a method of making compounds of Formula B and/or Amberketal comprising the step of making a compound of Formula (II), a compound of Formula (III) or a mixture thereof, Formula (II) Formula (III) by contacting a compound of Formula (IV) with a catalyst comprising a metal M complexed with a salen ligand of formula (I) or with a catalyst of formula (X) comprising a metal M complexed with a salen ligand
  • the present invention is based on the surprising finding that a catalyst comprising a metal M complexed with a salen ligand selectively oxidizes a compound of Formula (IV) at the 1 ,3-diene unit, producing a compound of Formula (II), a compound of Formula (III), or a mixture thereof.
  • a catalyst comprising a metal M complexed with a salen ligand of formula (I) wherein each R 1 is independently hydrogen, an alkyl group, an aryl group, or both R 1 together with the carbon atoms to which R 1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R 2 is independently hydrogen or an alkyl group, or both R 2 together with the carbon atoms to which R 2 are attached form a cycloalkylene group or an arylene group;
  • R 3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group; m is selected from 0 to 4.
  • each R 1 is independently hydrogen, a C1 to C10 alkyl group, or a C5 to C10 aryl group or both R 1 together with the carbon atoms to which R 1 are attached form a C5 to C10 cycloalkylene group, a C5 to C10 arylene group, two or more C5 to C10 cycloalkylene groups connected by a single bond or a C1 to C5 alkyl group (for example, a methyl group), two or more C5 to C10 arylene groups connected by a single bond or a C1 to C5 alkyl group (for example, a methyl group) or a C5 to C10 cycloalkylene group and a C5 to C10 arylene group connected by a single bond or a C1 to C5 alkyl group (
  • each R 1 is the same or different, or both R 1 together with the carbon atoms to which R 1 are attached form a cycloalkylene group. In some examples, each R 1 is the same. In some examples, both R 1 together with the carbon atoms to which R 1 are attached form a cycloalkylene group, wherein m is optionally 0.
  • each R 1 is independently hydrogen, a C1 to C10 alkyl group, or a C5 to C10 aryl group or both R 1 together with the carbon atoms to which R 1 are attached form a C5 to C10 cycloalkylene group. In some examples, both R 1 together with the carbon atoms to which R 1 are attached form a C5 to C10 cycloalkylene group and wherein m is 0. In some examples, each R 1 is independently a C1 to C6 alkyl group, or a C5 or C6 aryl group or both R 1 together with the carbon atoms to which R 1 are attached are a C5 to C7 cycloalkylene group and m is optionally 0. In some examples, both R 1 together with the carbon atoms to which R 1 are attached form a cyclohexylene group and m is 0.
  • each R 2 is independently hydrogen or a C1 to C10 alkyl group. In some examples, each R 2 is the same or different. In some examples, each R 2 is the same. In some examples, each R 2 is hydrogen. In some examples, each or both R 2 form together with the carbon atoms to which R 2 are attached a cycloalkylene group, for example a C5 to C7 cycloalkylene group, or an arylene group.
  • R 3 is selected from hydrogen, an optionally substituted C1 to C10 alkyl group, an optionally substituted C6 to C14 aryl group, hydroxyl or an amino group.
  • the salen ligand of formula (I) may contain chiral centers, and therefore might be present as an optically active mixture or a racemic mixture.
  • m is selected from 0 to 1. In some examples, m is 0.
  • a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein the metal M is selected from the group consisting of Mn and V.
  • Such metals allow for a good efficiency of the epoxidation reaction, and they are available at an affordable price.
  • the metal M is Mn. Catalysts with Mn as metal M show good performance in terms of turnover and selectivity.
  • the metal M can be provided as a salt, for example selected from the group consisting of Mn(acac) 2 , Mn(OAc) 2 , MnCI 2 , MnF 2 , MnPO 4 , MnSO 4 , MnO 2 , Mnl 2 , MnO, Mn(NO 3 ) 2 , MnCO 3 , VOSO 4 , VO(acac) 2 or the corresponding hydrate.
  • the metal M can be selected from the group consisting of Mn(acac) 3 , Mn(OAc) 3 or the corresponding hydrate.
  • the metal M salt is Mn(acac) 2 , Mn(OAc) 2 , MnCI 2 .
  • a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein the metal M is further complexed with a further ligand Y selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide (for example methoxide or ethoxide).
  • the further ligand Y is acetate.
  • the further ligand Y is capable of coordination, for example axial coordination, with the metal of the catalyst or can be present as counter ion.
  • the further ligand Y enables easier purification of the catalyst by crystallization, while the catalyst remains efficient and selective during the epoxidation reaction. Said purification is beneficial for the simplicity of the process and handling of the catalyst.
  • the further ligand Y can be provided as a salt, for example as sodium, lithium, silver, or quaternary amine salt.
  • the further ligand Y can be provided along with the metal M in the form of its salt.
  • the further ligand Y can be provided by the addition of an alkoxyde: potassium, lithium, sodium methoxide, ethoxide, tert-butoxide, tertamylate.
  • Such complexes comprising the further ligand Y can provide good yields and selectivity for the epoxidation reaction.
  • a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein R 1 , R 2 and R 3 is hydrogen.
  • a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein m is 0.
  • a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein R 1 , R 2 and R 3 is hydrogen and m is 0.
  • the diamine bridging unit of the salen ligand can be designed simple, as it does not affect the regioselectivity. Therefore, by reducing the complexity of the salen ligand, the cost of the catalysts can be reduced.
  • a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein R 1 , R 2 and R 3 is hydrogen, m is 0, the metal is Mn, and wherein the metal M is further complexed with a further ligand Y selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide.
  • the further ligand Y is acetate.
  • a catalyst of formula (X) comprising a metal M complexed with a salen ligand
  • each R 1 is independently hydrogen, an alkyl group, an aryl group, or both R 1 together with the carbon atoms to which R 1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R 2 is independently hydrogen or an alkyl group, or both R 2 together with the carbon atoms to which R 2 are attached form a cycloalkylene group or an arylene group;
  • R 3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group;
  • R 4 is selected from tert-butyl and tert-pentyl; m is selected from 0 to 4; the metal M is selected from the group consisting of Mn and V; and
  • Y is selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide.
  • each R 1 is independently hydrogen, a C1 to C10 alkyl group, or a C5 to C10 aryl group or both R 1 together with the carbon atoms to which R 1 are attached form a C5 to C10 cycloalkylene group, a C5 to C10 arylene group, two or more C5 to C10 cycloalkylene groups connected by a single bond or a C1 to C5 alkyl group (for example, a methyl group), two or more C5 to C10 arylene groups connected by a single bond or a C1 to C5 alkyl group (for example, a methyl group) or a C5 to C10 cycloalkylene group and a C5 to C10 arylene group connected by a single bond or a C1 to C5 alkyl group (for example, a methyl group).
  • each R 1 is the same or different, or both R 1 together with the carbon atoms to which R 1 are attached form a cycloalkylene group. In some examples, each R 1 is the same. In some examples, both R 1 together with the carbon atoms to which R 1 are attached form a cycloalkylene group, wherein m is optionally 0.
  • each R 1 is independently hydrogen, a C1 to C10 alkyl group, or a C5 to C10 aryl group or both R 1 together with the carbon atoms to which R 1 are attached form a C5 to C10 cycloalkylene group. In some examples, both R 1 together with the carbon atoms to which R 1 are attached form a C5 to C10 cycloalkylene group and wherein m is 0. In some examples, each R 1 is independently a C1 to C6 alkyl group, or a C5 or C6 aryl group or both R 1 together with the carbon atoms to which R 1 are attached are a C5 to C7 cycloalkylene group and m is optionally 0. In some examples, both R 1 together with the carbon atoms to which R 1 are attached form a cyclohexylene group and m is 0.
  • each R 2 is independently hydrogen or a C1 to C10 alkyl group. In some examples, each R 2 is the same or different. In some examples, each R 2 is the same. In some examples, each R 2 is hydrogen. In some examples, each or both R 2 form together with the carbon atoms to which R 2 are attached a cycloalkylene group, for example a C5 to C7 cycloalkylene group, or an arylene group.
  • R 3 is selected from hydrogen, an optionally substituted C1 to C10 alkyl group, an optionally substituted C6 to C14 aryl group, hydroxyl or an amino group.
  • R 4 is selected from tert-butyl (f-Bu) and tertpentyl (f-Pe). In some examples, each R 4 is the same or different. In some examples, each R 4 is the same.
  • the catalyst of formula (X) may contain chiral centers, and therefore might be present as an optically active mixture or a racemic mixture.
  • m is selected from 0 to 4, preferably from 0 to 1. In some examples, m is 0.
  • the metal M is selected from the group consisting of Mn and V, preferably Mn.
  • Y is selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide (for example methoxide or ethoxide).
  • R 1 , R 2 and R 3 is hydrogen.
  • m 0.
  • R 1 , R 2 and R 3 is hydrogen and m is 0.
  • R 1 , R 2 and R 3 is hydrogen, m is 0, the metal is
  • ligand Y is selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide (for example methoxide or ethoxide).
  • the ligand Y is acetate.
  • the catalyst comprising a metal M complexed with a salen ligand of formula (I) and/or the catalyst of formula (X) is useful for the efficient and selective epoxidation of [3-farnesene, the compound of Formula (IV).
  • the catalyst can be used for the selective epoxidation of the diene unit of the compound of Formula (IV), leading to the compound of Formula (II), the compound of Formula (III) or a mixture thereof. It is particularly surprising that neither of the other double bonds in the compound of Formula (IV) are oxidized, resulting in only two of the possible regioisomeric products.
  • the method comprises the steps of: a) mixing the salen ligand of formula (I) with a metal salt in a solvent, b) treating said mixture with an oxidant (preferable H 2 O 2 , oxygen, air, NaOCI, t-BuOOH), and c) optionally adding a salt to introduce the further ligand Y.
  • an oxidant preferable H 2 O 2 , oxygen, air, NaOCI, t-BuOOH
  • the solvent of step a) can be any solvent.
  • the solvent is methanol, ethanol, or dichloromethane, or a mixture comprising one or more of those solvents.
  • the oxidant of step b) is selected from the group consisting of H 2 O 2 , oxygen, air, NaOCI, ‘-BuOOH.
  • the optional addition of a salt to introduce the further ligand Y is required, when it is not provided already with the metal salt.
  • the method comprises the steps of: a) mixing the salen ligand with a metal salt in a solvent, b) treating said mixture with an oxidant (preferable H 2 O 2 , oxygen, air, NaOCI, t-BuOOH), and optionally adding a salt to introduce the further ligand Y.
  • an oxidant preferable H 2 O 2 , oxygen, air, NaOCI, t-BuOOH
  • the solvent of step a) can be any solvent.
  • the solvent is methanol, ethanol, or dichloromethane, or a mixture comprising one or more of those solvents.
  • the oxidant of step b) is selected from the group consisting of H 2 O 2 , oxygen, air, NaOCI, ‘-BuOOH.
  • the optional addition of a salt to introduce the further ligand Y is required, when it is not provided already with the metal salt.
  • each R 1 is independently hydrogen, an alkyl group, an aryl group, or both R 1 together with the carbon atoms to which R 1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R 2 is independently hydrogen or an alkyl group, or both R 2 together with the carbon atoms to which R 2 are attached form a cycloalkylene group or an arylene group;
  • R 3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group; m is selected from 0 to 4.
  • each R 1 is independently hydrogen, a C1 to C10 alkyl group, or a C5 to C10 aryl group or both R 1 together with the carbon atoms to which R 1 are attached form a C5 to C10 cycloalkylene group, a C5 to C10 arylene group, two or more C5 to C10 cycloalkylene groups connected by a single bond or a C1 to C5 alkyl group (for example, a methyl group), two or more C5 to C10 arylene groups connected by a single bond or a C1 to C5 alkyl group
  • each R 1 is the same or different, or both R 1 together with the carbon atoms to which R 1 are attached form a cycloalkylene group. In some examples, each R 1 is the same. In some examples, both R 1 together with the carbon atoms to which R 1 are attached form a cycloalkylene group, wherein m is optionally 0.
  • each R 2 is independently hydrogen or a C1 to C10 alkyl group. In some examples, each R 2 is the same or different. In some examples, each R 2 is the same. In some examples, each R 2 is hydrogen. In some examples, each or both R 2 form together with the carbon atoms to which R 2 are attached a cycloalkylene group, for example a C5 to C7 cycloalkylene group, or an arylene group.
  • R 3 is selected from hydrogen, an optionally substituted C1 to C10 alkyl group, an optionally substituted C6 to C14 aryl group, hydroxyl or an amino group.
  • the salen ligand of formula (I) may contain chiral centers, and therefore might be present as an optically active mixture or a racemic mixture.
  • n is selected from 0 to 1. In some examples, m is 0.
  • a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein the metal M is selected from the group consisting of Mn and V.
  • the metal M is Mn.
  • a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein the metal M is further complexed with a further ligand Y selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide (for example methoxide or ethoxide).
  • the further ligand Y is acetate.
  • a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein R 1 , R 2 and R 3 is hydrogen.
  • a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein m is 0. In some examples, there is provided a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein R 1 , R 2 and R 3 is hydrogen and m is 0.
  • the catalyst with a salen ligand of formula (I), having tert-pentyl (f-Pe) residues in a specific substitution pattern on the phenyl rings is useful for the efficient and selective epoxidation of P-farnesene, the compound of Formula (IV).
  • the catalyst can be used for the selective epoxidation of the diene unit of the compound of Formula (IV), leading to the compound of Formula (II), the compound of Formula (III) or a mixture thereof. It is particularly surprising that neither of the other double bonds in the compound of Formula (IV) are oxidized, resulting in only two of the possible regioisomeric products.
  • the specific substitution pattern has a strong impact on the turnover, allowing the use of this catalyst with much lower quantities.
  • the compound of Formula (IV) is [3-farnesene, an isomer of farnesene, which may be referred to as 7,11 -dimethyl-3-methylene- 1 ,6,10-dodecatriene.
  • the compound of Formula (IV) may be (6E)-[3-farnesene, which may be referred to as 7,11-dimethyl-3-methylene-1 ,6E,10- dodecatriene.
  • the compound of Formula (IV) may be the compound with CAS number [18794- 84-8] or the compound with CAS number [77129-48-7],
  • the stereochemistry of the double bond i.e., the double bond between C6 and C7 of the compound of Formula (IV)
  • the compound of formula (IV) may be replaced by a mixture comprising optionally further isomers of farnesene, e.g. (6Z)-[3-farnesene (CAS 28973-97-9) and a-farnesene (3,7,11- trimethyldodeca-1 ,3,6,10-tetraene) which includes (E,E)-a-farnesene (CAS 502-61-4), (Z,E)-a- farnesene (CAS 26560-14-5), (E,Z)-a-farnesene (CAS 28973-98-0) and (Z,Z)-a-farnesene (CAS 28973-99-1), cyclic isomers might be also present.
  • 6Z farnesene
  • 6Z [3-farnesene (CAS 28973-97-9) and a-farnesene (3,7,11- trimethyldodeca-1 ,3,6,10-tetraene) which includes (E,E)-a-farnesen
  • the method for making a compound of Formula (II), a compound of Formula (III) or a mixture thereof wherein the catalyst comprises a metal M complexed with a salen ligand of formula (I) as described above, wherein R 1 , R 2 and R 3 is hydrogen, m is 0, the metal is Mn, and wherein the metal M is further complexed with a further ligand Y selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide.
  • the further ligand Y is acetate.
  • Formula (II) Formula (III) wherein the method comprises contacting a compound of Formula (IV) Formula (IV) with a catalyst of formula (X) comprising a metal M complexed with a salen ligand
  • each R 1 is independently hydrogen, an alkyl group, an aryl group, or both R 1 together with the carbon atoms to which R 1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R 2 is independently hydrogen or an alkyl group, or both R 2 together with the carbon atoms to which R 2 are attached form a cycloalkylene group or an arylene group; R 3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group;
  • R 4 is selected from tert-butyl and tert-pentyl; m is selected from 0 to 4; the metal M is selected from the group consisting of Mn and V; and
  • Y is selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide.
  • the method for making a compound of Formula (II), a compound of Formula (III) or a mixture thereof may be a method for making a mixture of a compound of Formula (II) and a compound of Formula (III).
  • the mixture of a compound of Formula (II) and a compound of Formula (III) may be about a 99:1 to about 1 :99 mixture, for example, about a 90:1 to about a 1 :90 mixture, about a 80:20 to 20:80 mixture, about a 60:40 to about a 40:60 mixture, for example, about a 59:41 to about a 41 :59 mixture, for example, about a 57:43 to about a 43:57 mixture or about a 50:50 mixture.
  • the mixture may be about a 1 :1 mixture of compounds of Formula (II) and Formula (III). In some examples, the mixture of a compound of Formula (II) and a compound of Formula (III) may be about a 43:57, or about 44:56, or about 45:55.
  • the catalyst is employed in about 0.01 - 0.6 mol% catalyst loading, preferably about 0.05 - 0.5 mol%, preferably about 0.1 - 0.4 mol%, for example 0.3 mol% catalyst loading.
  • the catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above is employed in about 0.01 - 0.6 mol% catalyst loading, preferably about 0.05 - 0.5 mol%, preferably about 0.1 - 0.4 mol%, for example 0.3 mol% catalyst loading.
  • the catalyst of formula (X) as described above is employed in about 0.01 - 0.6 mol% catalyst loading, preferably about 0.05 - 0.5 mol%, preferably about 0.1 - 0.4 mol%, for example 0.3 mol% catalyst loading.
  • Such a catalyst loading for the epoxidation of the compound of Formula (IV) provides the desired product with a high yield and conversion.
  • a relative low catalyst loading is providing an improved yield and conversion.
  • the step of contacting the compound of Formula (IV) with a catalyst comprising a metal M complexed with a salen ligand of formula (I) or with a catalyst of formula (X) comprising a metal M complexed with a salen ligand is carried out in the presence of an oxidant.
  • the oxidant may be selected from a hypochlorite, a peroxide, a periodate, a percarbonate and molecular oxygen.
  • the hypochlorite may be sodium hypochlorite (NaOCI), sodium hypobromite (NaOBr) or Calcium hypochlorite (Ca(OCI) 2 ).
  • the peroxide may be hydrogen peroxide, anhydrous urea-hydrogen peroxide, dimethyldioxirane, or tert-butylhydroperoxide (tBuOOH).
  • the periodate may be IO 4 _ or IO 6 5- .
  • the percarbonate may be sodium percarbonate (Na 2 CO 3 - 1.5 H 2 O 2 ).
  • the oxidant may be sodium hypochlorite or hydrogen peroxide.
  • oxidant For example, about 1 eq. of the oxidant is needed to obtain the epoxidation reaction in good yields and in reasonable time. However, also lower or higher amounts of the oxidant can be used.
  • the compound of Formula (II), the compound of Formula (III) or a mixture thereof, obtained by the methods described above can be further converted by methods as described in WO2022/268840A1 and WO2024/023154 into compounds of Formula B, which are useful intermediates in the production of Amberketal and Amberketal homologues.
  • Formula B Formula A the method comprising the step of making a compound of Formula (II), a compound of Formula
  • Formula (II) Formula (III) wherein the method comprises contacting a compound of Formula (IV) with a catalyst comprising a metal M complexed with a salen ligand of formula (I) or with a catalyst of formula (X) comprising a metal M complexed with a salen ligand
  • 2-hydroxy-3,5-di-tert-pentylbenzaldehyde can be synthesized, starting from 2,4-di-terf- pentylphenol and following different procedures described in the literature, for example in Journal of Organic Chemistry, 67, 2702-2704, 2002, or in Organic Letters, 24(38), 6968-6972, 2022.
  • 6,6'-((1E,1'E)-(ethane-1 ,2-diylbis(azaneylylidene))-bis(methaneylylidene))-bis(2,4-di-ferf- pentyl-phenol) can be synthesized according to the procedure described in the following publication: Inorganica Chimica Acta, 359, 197-203, 2006.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Catalysts (AREA)

Abstract

There is provided a method for the selective epoxidation of farnesene using a catalyst comprising a metal M complexed with a salen ligand of formula (I).

Description

PROCESS
TECHNICAL FIELD
The present invention relates to improved catalysts for selective epoxidation and to improved methods for making intermediates in the production of fragrances such as Amberketal and Amberketal homologues by epoxidation starting from [3-farnesene.
BACKGROUND
Amberketal provides a powerful and tenacious ambery and woody odour that is useful in fragrance compositions alone or in combination with other woody or ambery ingredients. Amberketal is traditionally prepared from Manool via a number of chemical transformations. However, the supply of natural Manool is limited. It is therefore desirable to provide a new efficient and cost effective synthetic route to obtain Amberketal and Amberketal homologues.
A synthetic route to Amberketal homologues (Formula A) comprising contacting a compound of Formula B (wherein R1 is H, methyl or ethyl) with a squalene-hopene cyclase (SHC) enzyme or enzyme variant has been disclosed in WO2021/209482 (PCT/EP2021/059618).
Formula B Formula A
An access to the compound of formula B is described in WO2022/268840 and in WO2024/023154. Both synthetic routes begin with a selective epoxidation of [3-farnesene, leading to a mixture of two epoxides, one of which is further converted to the compound of formula B.
It is therefore desirable to provide a new efficient access to the desired epoxide of [3-farnesene to improve the access to compounds of Formula B, which can then be used in the production of Amberketal and Amberketal homologues.
SUMMARY In accordance with a first aspect of the present invention there is provided a catalyst comprising a metal M complexed with a salen ligand of formula (I) wherein each R1 is independently hydrogen, an alkyl group, an aryl group, or both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R2 is independently hydrogen or an alkyl group, or both R2 together with the carbon atoms to which R2 are attached form a cycloalkylene group or an arylene group;
R3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group; m is selected from 0 to 4.
In accordance with a second aspect of the present invention there is provided a catalyst of formula (X) comprising a metal M complexed with a salen ligand wherein each R1 is independently hydrogen, an alkyl group, an aryl group, or both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R2 is independently hydrogen or an alkyl group, or both R2 together with the carbon atoms to which R2 are attached form a cycloalkylene group or an arylene group;
R3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group;
R4 is selected from tert-butyl and tert-pentyl; m is selected from 0 to 4; the metal M is selected from the group consisting of Mn and V; and
Y is selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide.
In accordance with a third aspect of the present invention there is provided a method for making a catalyst comprising a metal M complexed with a salen ligand of formula (I)
In accordance with a fourth aspect of the present invention there is provided a method for making a catalyst of formula (X) comprising a metal M complexed with a salen ligand
Formula (X). In accordance with a fifth aspect of the present invention there is provided a method for making a compound of Formula (II), a compound of Formula (III) or a mixture thereof,
Formula (II) Formula (III) wherein the method comprises contacting a compound of Formula (IV) with a catalyst comprising a metal M complexed with a salen ligand of formula (I) wherein each R1 is independently hydrogen, an alkyl group, an aryl group, or both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R2 is independently hydrogen or an alkyl group, or both R2 together with the carbon atoms to which R2 are attached form a cycloalkylene group or an arylene group;
R3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group; m is selected from 0 to 4;
In accordance with a sixth aspect of the present invention there is provided a method for making a compound of Formula (II), a compound of Formula (III) or a mixture thereof,
Formula (II) Formula (III) wherein the method comprises contacting a compound of Formula (IV) with a catalyst of formula (X) comprising a metal M complexed with a salen ligand wherein each R1 is independently hydrogen, an alkyl group, an aryl group, or both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R2 is independently hydrogen or an alkyl group, or both R2 together with the carbon atoms to which R2 are attached form a cycloalkylene group or an arylene group;
R3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group;
R4 is selected from tert-butyl and tert-pentyl; m is selected from 0 to 4; the metal M is selected from the group consisting of Mn and V; and
Y is selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide. In accordance with a seventh aspect of the present invention there is provided, there is provided a method of making compounds of Formula B and/or Amberketal, the method comprising the step of making a compound of Formula (II), a compound of Formula (III) or a mixture thereof, Formula (II) Formula (III) by contacting a compound of Formula (IV) with a catalyst comprising a metal M complexed with a salen ligand of formula (I) or with a catalyst of formula (X) comprising a metal M complexed with a salen ligand
Certain embodiments of any aspect of the present invention may provide one or more of the following advantages:
Efficient and selective epoxidation;
Easier handling of the catalyst; • Lower catalyst loading required; and
• Simple catalyst design.
The details, examples and preferences provided in relation to any particular one or more of the stated aspects of the present invention will be further described herein and apply equally to all aspects of the present invention. Any combination of the embodiments, examples and preferences described herein in all possible variations thereof is encompassed by the present invention unless otherwise indicated herein, or otherwise clearly contradicted by context.
DETAILED DESCRIPTION
The present invention is based on the surprising finding that a catalyst comprising a metal M complexed with a salen ligand selectively oxidizes a compound of Formula (IV) at the 1 ,3-diene unit, producing a compound of Formula (II), a compound of Formula (III), or a mixture thereof.
There is therefore provided herein a catalyst comprising a metal M complexed with a salen ligand of formula (I) wherein each R1 is independently hydrogen, an alkyl group, an aryl group, or both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R2 is independently hydrogen or an alkyl group, or both R2 together with the carbon atoms to which R2 are attached form a cycloalkylene group or an arylene group;
R3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group; m is selected from 0 to 4. In some examples, each R1 is independently hydrogen, a C1 to C10 alkyl group, or a C5 to C10 aryl group or both R1 together with the carbon atoms to which R1 are attached form a C5 to C10 cycloalkylene group, a C5 to C10 arylene group, two or more C5 to C10 cycloalkylene groups connected by a single bond or a C1 to C5 alkyl group (for example, a methyl group), two or more C5 to C10 arylene groups connected by a single bond or a C1 to C5 alkyl group (for example, a methyl group) or a C5 to C10 cycloalkylene group and a C5 to C10 arylene group connected by a single bond or a C1 to C5 alkyl group (for example, a methyl group). In some examples, each R1 is the same or different, or both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group. In some examples, each R1 is the same. In some examples, both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group, wherein m is optionally 0.
In some examples, each R1 is independently hydrogen, a C1 to C10 alkyl group, or a C5 to C10 aryl group or both R1 together with the carbon atoms to which R1 are attached form a C5 to C10 cycloalkylene group. In some examples, both R1 together with the carbon atoms to which R1 are attached form a C5 to C10 cycloalkylene group and wherein m is 0. In some examples, each R1 is independently a C1 to C6 alkyl group, or a C5 or C6 aryl group or both R1 together with the carbon atoms to which R1 are attached are a C5 to C7 cycloalkylene group and m is optionally 0. In some examples, both R1 together with the carbon atoms to which R1 are attached form a cyclohexylene group and m is 0.
In some examples, each R2 is independently hydrogen or a C1 to C10 alkyl group. In some examples, each R2 is the same or different. In some examples, each R2 is the same. In some examples, each R2 is hydrogen. In some examples, each or both R2 form together with the carbon atoms to which R2 are attached a cycloalkylene group, for example a C5 to C7 cycloalkylene group, or an arylene group.
In some examples, R3 is selected from hydrogen, an optionally substituted C1 to C10 alkyl group, an optionally substituted C6 to C14 aryl group, hydroxyl or an amino group.
Due to the nature of residues R1, R2 and/ or R3, the salen ligand of formula (I) may contain chiral centers, and therefore might be present as an optically active mixture or a racemic mixture.
In some examples, m is selected from 0 to 1. In some examples, m is 0. For example, there is provided herein a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein the metal M is selected from the group consisting of Mn and V. Such metals allow for a good efficiency of the epoxidation reaction, and they are available at an affordable price.
In some examples, the metal M is Mn. Catalysts with Mn as metal M show good performance in terms of turnover and selectivity.
For example, the metal M can be provided as a salt, for example selected from the group consisting of Mn(acac)2, Mn(OAc)2, MnCI2, MnF2, MnPO4, MnSO4, MnO2, Mnl2, MnO, Mn(NO3)2, MnCO3, VOSO4, VO(acac)2 or the corresponding hydrate. Alternatively, the metal M can be selected from the group consisting of Mn(acac)3, Mn(OAc)3 or the corresponding hydrate. For example, the metal M salt is Mn(acac)2, Mn(OAc)2, MnCI2.
Without being bound by theory, applicant believes that the metal can be provided in different forms, which are then converted, if necessary, to Mn=O complexed by the ligand, thereby forming the effecting catalyst.
For example, there is provided herein a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein the metal M is further complexed with a further ligand Y selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide (for example methoxide or ethoxide). In some examples, the further ligand Y is acetate.
The further ligand Y is capable of coordination, for example axial coordination, with the metal of the catalyst or can be present as counter ion. The further ligand Y enables easier purification of the catalyst by crystallization, while the catalyst remains efficient and selective during the epoxidation reaction. Said purification is beneficial for the simplicity of the process and handling of the catalyst.
For example, the further ligand Y can be provided as a salt, for example as sodium, lithium, silver, or quaternary amine salt. For example, the further ligand Y can be provided along with the metal M in the form of its salt. Alternatively, the further ligand Y can be provided by the addition of an alkoxyde: potassium, lithium, sodium methoxide, ethoxide, tert-butoxide, tertamylate. Such complexes comprising the further ligand Y can provide good yields and selectivity for the epoxidation reaction.
In some examples, there is provided a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein R1, R2 and R3 is hydrogen.
In some examples, there is a provided a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein m is 0.
In some examples, there is provided a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein R1, R2 and R3 is hydrogen and m is 0.
For the desired epoxidation of [3-farnesene the diamine bridging unit of the salen ligand can be designed simple, as it does not affect the regioselectivity. Therefore, by reducing the complexity of the salen ligand, the cost of the catalysts can be reduced.
However, also more complex salen ligands, for example with chiral diamine bridging units, can be used to obtain efficient and selective epoxidation of the compound of Formula (IV). Typically, such salen ligands would influence the enantioselectivity of a reaction, which, however, does not apply in the present case.
In some examples, there is provided a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein R1, R2 and R3 is hydrogen, m is 0, the metal is Mn, and wherein the metal M is further complexed with a further ligand Y selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide. In some examples, the further ligand Y is acetate.
In a further aspect of the present invention, there is provided a catalyst of formula (X) comprising a metal M complexed with a salen ligand
Formula (X) wherein each R1 is independently hydrogen, an alkyl group, an aryl group, or both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R2 is independently hydrogen or an alkyl group, or both R2 together with the carbon atoms to which R2 are attached form a cycloalkylene group or an arylene group;
R3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group;
R4 is selected from tert-butyl and tert-pentyl; m is selected from 0 to 4; the metal M is selected from the group consisting of Mn and V; and
Y is selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide.
In some examples of the catalyst of formula (X), each R1 is independently hydrogen, a C1 to C10 alkyl group, or a C5 to C10 aryl group or both R1 together with the carbon atoms to which R1 are attached form a C5 to C10 cycloalkylene group, a C5 to C10 arylene group, two or more C5 to C10 cycloalkylene groups connected by a single bond or a C1 to C5 alkyl group (for example, a methyl group), two or more C5 to C10 arylene groups connected by a single bond or a C1 to C5 alkyl group (for example, a methyl group) or a C5 to C10 cycloalkylene group and a C5 to C10 arylene group connected by a single bond or a C1 to C5 alkyl group (for example, a methyl group). In some examples, each R1 is the same or different, or both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group. In some examples, each R1 is the same. In some examples, both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group, wherein m is optionally 0.
In some examples of the catalyst of formula (X), each R1 is independently hydrogen, a C1 to C10 alkyl group, or a C5 to C10 aryl group or both R1 together with the carbon atoms to which R1 are attached form a C5 to C10 cycloalkylene group. In some examples, both R1 together with the carbon atoms to which R1 are attached form a C5 to C10 cycloalkylene group and wherein m is 0. In some examples, each R1 is independently a C1 to C6 alkyl group, or a C5 or C6 aryl group or both R1 together with the carbon atoms to which R1 are attached are a C5 to C7 cycloalkylene group and m is optionally 0. In some examples, both R1 together with the carbon atoms to which R1 are attached form a cyclohexylene group and m is 0.
In some examples of the catalyst of formula (X), each R2 is independently hydrogen or a C1 to C10 alkyl group. In some examples, each R2 is the same or different. In some examples, each R2 is the same. In some examples, each R2 is hydrogen. In some examples, each or both R2 form together with the carbon atoms to which R2 are attached a cycloalkylene group, for example a C5 to C7 cycloalkylene group, or an arylene group.
In some examples of the catalyst of formula (X), R3 is selected from hydrogen, an optionally substituted C1 to C10 alkyl group, an optionally substituted C6 to C14 aryl group, hydroxyl or an amino group.
In some examples of the catalyst of formula (X), R4 is selected from tert-butyl (f-Bu) and tertpentyl (f-Pe). In some examples, each R4 is the same or different. In some examples, each R4 is the same.
Due to the nature of residues R1, R2 and/ or R3, the catalyst of formula (X) may contain chiral centers, and therefore might be present as an optically active mixture or a racemic mixture.
In some examples of the catalyst of formula (X), m is selected from 0 to 4, preferably from 0 to 1. In some examples, m is 0.
In some examples of the catalyst of formula (X), the metal M is selected from the group consisting of Mn and V, preferably Mn.
In some examples of the catalyst of formula (X), Y is selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide (for example methoxide or ethoxide).
In some examples of the catalyst of formula (X), R1, R2 and R3 is hydrogen.
In some examples of the catalyst of formula (X), m is 0.
In some examples of the catalyst of formula (X), R1, R2 and R3 is hydrogen and m is 0.
In some examples of the catalyst of formula (X), R1, R2 and R3 is hydrogen, m is 0, the metal is
Mn, ligand Y is selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide (for example methoxide or ethoxide). In some examples, the ligand Y is acetate.
The catalyst comprising a metal M complexed with a salen ligand of formula (I) and/or the catalyst of formula (X) is useful for the efficient and selective epoxidation of [3-farnesene, the compound of Formula (IV). In particular, the catalyst can be used for the selective epoxidation of the diene unit of the compound of Formula (IV), leading to the compound of Formula (II), the compound of Formula (III) or a mixture thereof. It is particularly surprising that neither of the other double bonds in the compound of Formula (IV) are oxidized, resulting in only two of the possible regioisomeric products.
Furthermore, the selection of further ligand Y allows for an easier purification of the catalyst by crystallization, while the catalyst remains efficient and selective during the epoxidation reaction. Such a purification is beneficial for the simplicity of the process and handling of the catalyst.
In a further aspect of the present invention, there is provided a method for making a catalyst comprising a metal M complexed with a salen ligand of formula (I)
The method comprises the steps of: a) mixing the salen ligand of formula (I) with a metal salt in a solvent, b) treating said mixture with an oxidant (preferable H2O2, oxygen, air, NaOCI, t-BuOOH), and c) optionally adding a salt to introduce the further ligand Y.
For example, the solvent of step a) can be any solvent. For example, the solvent is methanol, ethanol, or dichloromethane, or a mixture comprising one or more of those solvents.
For example, the oxidant of step b) is selected from the group consisting of H2O2, oxygen, air, NaOCI, ‘-BuOOH. For example, the optional addition of a salt to introduce the further ligand Y is required, when it is not provided already with the metal salt.
In a further aspect of the present invention, there is provided a method for making a catalyst of formula (X) comprising a metal M complexed with a salen ligand
The method comprises the steps of: a) mixing the salen ligand with a metal salt in a solvent, b) treating said mixture with an oxidant (preferable H2O2, oxygen, air, NaOCI, t-BuOOH), and optionally adding a salt to introduce the further ligand Y.
For example, the solvent of step a) can be any solvent. For example, the solvent is methanol, ethanol, or dichloromethane, or a mixture comprising one or more of those solvents.
For example, the oxidant of step b) is selected from the group consisting of H2O2, oxygen, air, NaOCI, ‘-BuOOH.
For example, the optional addition of a salt to introduce the further ligand Y is required, when it is not provided already with the metal salt.
In a further aspect of the present invention, there is provided herein a method for making a compound of Formula (II), a compound of Formula (III) or a mixture thereof, Formula (II) Formula (III) wherein the method comprises contacting a compound of Formula (IV) Formula (IV) with a catalyst comprising a metal M complexed with a salen ligand of formula (I)
Formula (I) wherein each R1 is independently hydrogen, an alkyl group, an aryl group, or both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R2 is independently hydrogen or an alkyl group, or both R2 together with the carbon atoms to which R2 are attached form a cycloalkylene group or an arylene group;
R3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group; m is selected from 0 to 4.
In some examples, each R1 is independently hydrogen, a C1 to C10 alkyl group, or a C5 to C10 aryl group or both R1 together with the carbon atoms to which R1 are attached form a C5 to C10 cycloalkylene group, a C5 to C10 arylene group, two or more C5 to C10 cycloalkylene groups connected by a single bond or a C1 to C5 alkyl group (for example, a methyl group), two or more C5 to C10 arylene groups connected by a single bond or a C1 to C5 alkyl group
(for example, a methyl group) or a C5 to C10 cycloalkylene group and a C5 to C10 arylene group connected by a single bond or a C1 to C5 alkyl group (for example, a methyl group). In some examples, each R1 is the same or different, or both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group. In some examples, each R1 is the same. In some examples, both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group, wherein m is optionally 0.
In some examples, each R2 is independently hydrogen or a C1 to C10 alkyl group. In some examples, each R2 is the same or different. In some examples, each R2 is the same. In some examples, each R2 is hydrogen. In some examples, each or both R2 form together with the carbon atoms to which R2 are attached a cycloalkylene group, for example a C5 to C7 cycloalkylene group, or an arylene group.
In some examples, R3 is selected from hydrogen, an optionally substituted C1 to C10 alkyl group, an optionally substituted C6 to C14 aryl group, hydroxyl or an amino group.
Due to the nature of residues R1, R2 and/ or R3, the salen ligand of formula (I) may contain chiral centers, and therefore might be present as an optically active mixture or a racemic mixture.
In some examples, m is selected from 0 to 1. In some examples, m is 0.
For example, there is provided herein a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein the metal M is selected from the group consisting of Mn and V. In some examples, the metal M is Mn.
For example, there is provided herein a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein the metal M is further complexed with a further ligand Y selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide (for example methoxide or ethoxide). In some examples, the further ligand Y is acetate.
In some examples, there is a provided a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein R1, R2 and R3 is hydrogen.
In some examples, there is a provided a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein m is 0. In some examples, there is provided a catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above, wherein R1, R2 and R3 is hydrogen and m is 0.
The catalyst with a salen ligand of formula (I), having tert-pentyl (f-Pe) residues in a specific substitution pattern on the phenyl rings, is useful for the efficient and selective epoxidation of P-farnesene, the compound of Formula (IV). In particular, the catalyst can be used for the selective epoxidation of the diene unit of the compound of Formula (IV), leading to the compound of Formula (II), the compound of Formula (III) or a mixture thereof. It is particularly surprising that neither of the other double bonds in the compound of Formula (IV) are oxidized, resulting in only two of the possible regioisomeric products. The specific substitution pattern has a strong impact on the turnover, allowing the use of this catalyst with much lower quantities.
Furthermore, the selectivity of the epoxidation reaction towards the formation of the compound of Formula (III) (the exo-isomer) is slightly impacted by the number, position and selection of the alkyl residues at the benzene rings of the salen ligand.
The compound of Formula (IV) is [3-farnesene, an isomer of farnesene, which may be referred to as 7,11 -dimethyl-3-methylene- 1 ,6,10-dodecatriene. The compound of Formula (IV) may be (6E)-[3-farnesene, which may be referred to as 7,11-dimethyl-3-methylene-1 ,6E,10- dodecatriene. The compound of Formula (IV) may be the compound with CAS number [18794- 84-8] or the compound with CAS number [77129-48-7], The stereochemistry of the double bond (i.e., the double bond between C6 and C7 of the compound of Formula (IV)) remains unchanged during the method for making a compound of Formula (II), a compound of Formula (III) or a mixture thereof.
The compound of formula (IV) may be replaced by a mixture comprising optionally further isomers of farnesene, e.g. (6Z)-[3-farnesene (CAS 28973-97-9) and a-farnesene (3,7,11- trimethyldodeca-1 ,3,6,10-tetraene) which includes (E,E)-a-farnesene (CAS 502-61-4), (Z,E)-a- farnesene (CAS 26560-14-5), (E,Z)-a-farnesene (CAS 28973-98-0) and (Z,Z)-a-farnesene (CAS 28973-99-1), cyclic isomers might be also present.
For example, there is provided the method for making a compound of Formula (II), a compound of Formula (III) or a mixture thereof, wherein the catalyst comprises a metal M complexed with a salen ligand of formula (I) as described above, wherein R1, R2 and R3 is hydrogen, m is 0, the metal is Mn, and wherein the metal M is further complexed with a further ligand Y selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide. In some examples, the further ligand Y is acetate.
There is further provided a method for making a compound of Formula (II), a compound of Formula (III) or a mixture thereof,
Formula (II) Formula (III) wherein the method comprises contacting a compound of Formula (IV) Formula (IV) with a catalyst of formula (X) comprising a metal M complexed with a salen ligand
Formula (X) wherein each R1 is independently hydrogen, an alkyl group, an aryl group, or both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R2 is independently hydrogen or an alkyl group, or both R2 together with the carbon atoms to which R2 are attached form a cycloalkylene group or an arylene group; R3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group;
R4 is selected from tert-butyl and tert-pentyl; m is selected from 0 to 4; the metal M is selected from the group consisting of Mn and V; and
Y is selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide.
The method for making a compound of Formula (II), a compound of Formula (III) or a mixture thereof may be a method for making a mixture of a compound of Formula (II) and a compound of Formula (III). In some examples, the mixture of a compound of Formula (II) and a compound of Formula (III) may be about a 99:1 to about 1 :99 mixture, for example, about a 90:1 to about a 1 :90 mixture, about a 80:20 to 20:80 mixture, about a 60:40 to about a 40:60 mixture, for example, about a 59:41 to about a 41 :59 mixture, for example, about a 57:43 to about a 43:57 mixture or about a 50:50 mixture. In some examples, the mixture may be about a 1 :1 mixture of compounds of Formula (II) and Formula (III). In some examples, the mixture of a compound of Formula (II) and a compound of Formula (III) may be about a 43:57, or about 44:56, or about 45:55.
For example, the catalyst is employed in about 0.01 - 0.6 mol% catalyst loading, preferably about 0.05 - 0.5 mol%, preferably about 0.1 - 0.4 mol%, for example 0.3 mol% catalyst loading.
For example, the catalyst comprising a metal M complexed with a salen ligand of formula (I) as described above is employed in about 0.01 - 0.6 mol% catalyst loading, preferably about 0.05 - 0.5 mol%, preferably about 0.1 - 0.4 mol%, for example 0.3 mol% catalyst loading.
For example, the catalyst of formula (X) as described above is employed in about 0.01 - 0.6 mol% catalyst loading, preferably about 0.05 - 0.5 mol%, preferably about 0.1 - 0.4 mol%, for example 0.3 mol% catalyst loading.
Such a catalyst loading for the epoxidation of the compound of Formula (IV) provides the desired product with a high yield and conversion. In comparison to catalysts known from prior art, a relative low catalyst loading is providing an improved yield and conversion. The step of contacting the compound of Formula (IV) with a catalyst comprising a metal M complexed with a salen ligand of formula (I) or with a catalyst of formula (X) comprising a metal M complexed with a salen ligand is carried out in the presence of an oxidant.
In some examples, the oxidant may be selected from a hypochlorite, a peroxide, a periodate, a percarbonate and molecular oxygen. In some examples, the hypochlorite may be sodium hypochlorite (NaOCI), sodium hypobromite (NaOBr) or Calcium hypochlorite (Ca(OCI)2). In some examples, the peroxide may be hydrogen peroxide, anhydrous urea-hydrogen peroxide, dimethyldioxirane, or tert-butylhydroperoxide (tBuOOH). In some examples, the periodate may be IO4 _ or IO6 5-. In some examples, the percarbonate may be sodium percarbonate (Na2CO3- 1.5 H2O2). In some examples, the oxidant may be sodium hypochlorite or hydrogen peroxide.
For example, about 1 eq. of the oxidant is needed to obtain the epoxidation reaction in good yields and in reasonable time. However, also lower or higher amounts of the oxidant can be used.
The compound of Formula (II), the compound of Formula (III) or a mixture thereof, obtained by the methods described above can be further converted by methods as described in WO2022/268840A1 and WO2024/023154 into compounds of Formula B, which are useful intermediates in the production of Amberketal and Amberketal homologues.
So in a further aspect of the present invention, there is provided a method of making compounds of Formula B and/or Amberketal,
Formula B Formula A the method comprising the step of making a compound of Formula (II), a compound of Formula
(III) or a mixture thereof,
Formula (II) Formula (III) wherein the method comprises contacting a compound of Formula (IV) with a catalyst comprising a metal M complexed with a salen ligand of formula (I) or with a catalyst of formula (X) comprising a metal M complexed with a salen ligand
Formula (X), with the catalyst as described above.
The invention is now further described with reference to the following non-limiting examples. These examples are for the purpose of illustration only, and it is understood that variations and modifications can be made by one skilled in the art. EXAMPLES
Example 1 : Synthesis of 2-hydroxy-3,5-di-tert-pentylbenzaldehyde
2-hydroxy-3,5-di-tert-pentylbenzaldehyde can be synthesized, starting from 2,4-di-terf- pentylphenol and following different procedures described in the literature, for example in Journal of Organic Chemistry, 67, 2702-2704, 2002, or in Organic Letters, 24(38), 6968-6972, 2022.
Example 2: Synthesis of 6,6'-((1E,TE)-(ethane-1 ,2-diylbis-(azaneylylidene))- bis(methaneylylidene))-bis(2,4-di-tert-pentylphenol)
6,6'-((1E,1'E)-(ethane-1 ,2-diylbis(azaneylylidene))-bis(methaneylylidene))-bis(2,4-di-ferf- pentyl-phenol) can be synthesized according to the procedure described in the following publication: Inorganica Chimica Acta, 359, 197-203, 2006.
Example 3: Synthesis of TCH-Mn-f-Pe-salen
6,6'-((1E,1'E)-(ethane-1 ,2-diylbis(azaneylylidene))-bis(methaneylylidene))-bis(2,4-di-ferf- pentylphenol) (10 g) was dissolved in ethanol (70 mL) under nitrogen. Manganese acetate tetrahydrate (5.4 g) and hydrogen peroxide (2.07 g, 30% wt) were added slowly over 5 min at room temperature. Sodium chloride (1.28 g) was then added and the dark brown reaction mixture was stirred at reflux for 2h. Ethanol was evaporated in vacuo and the residue was dissolved in dichloromethane/water (50%). The phases were separated and the aqueous layer was extracted once with dichloromethane (150 mL). The organic phases were combined and washed once with water (150 mL). The organic phase was dried over MgSO4, filtered and the solvent was removed in vacuo to give 11.7 g of [CI]-Mn-f-Pe-salen as a brown solid.
Anal. Calcd for Cseh^CIMnl^ (M 637.23): C, 67.86%; H, 8.54; N, 4.40. Found: C, 68.04%; H, 8.73; N, 4.44. LCMS (+) ESI (relative abundance): 601.4 (100%, [M - Cl]+).
Example 4: Synthesis of |AcO1-Mn-f-Pe-salen catalyst:
6,6'-((1E,1'E)-(ethane-1 ,2-diylbis(azaneylylidene))-bis(methaneylylidene))-bis(2,4-di-tert- pentylphenol) (125.0 g) was suspended in ethanol (1.11 L). Mn(OAc)2(H2O)4 (66.96 g) was added, followed by hydrogen peroxide (38.73 g, 30% wt). The mixture was heated to reflux and stirred for 1 h. Ethanol was removed in vacuo, methyl tert-butyl ether (MtBE) (1.1 L) was added to the residue which was then washed with water (850 mL). The organic solvent was removed under vacuo, heptane (660 mL) was added and the mixture was cooled to -20°C. The suspension was filtered and washed with cold heptane (150 mL). The brown solid was dried in vacuo to give [AcO]-Mn-f-Pe-salen (93.3 g) as a brown solid.
Anal. Calcd for C38H57MnN2O4 + C2H4O2 (M + AcOH 720.87): C, 66.65%; H, 8.53; N, 3.89. Found: C, 66.88%; H, 8.72; N, 4.06. LCMS (-) ESI (relative abundance): 719.5 (50%, [M + OAc] ) 660.8 (100%, [M] ), 646.9 (48%).
Example 5: Synthesis of TXI-Mn-f-Pe-salen catalyst:
(X: BF4‘, CF3SO3“ and NO3 ): AgX (X“ = BF4“, CF3SO3“, NO3“ ) (9.4 mmol) was respectively added to the [CI]-Mn-f-Pe-salen (3.1 mmol) in dichloromethane (78 ml) at room temperature and the mixture was stirred for 3 h. The mixture was then cooled to -10° and AgCI was filtered off. The filtrate was concentrated in vacuo to give crude [X]-Mn-f-Pe-salen.
[BF4]-f-Pe-Mn-salen: Crude [BF4]-f-Pe-Mn-salen (2.04 g) was suspended in heptane (14 mL) and heated to reflux for 30 minutes before being filtered hot. The suspension was filtered, washed with heptane and dried in vacuo to give 1.48 g of a brown solid.
LCMS (-) ESI (relative abundance): 775.4 (100%, [M+BF4] ), 688.5 (30%, [M] ), 646.5 (48%).
[TfO]- f-Pe-Mn-salen: Crude [TfO]- f-Pe-Mn-salen (2.26 g) was suspended in dichloromethane (7 mL) and heated to reflux for 30 minutes before being cooled down to 0°C. Cold pentane (12 mL) was added to the solution which was then aged at -20°C for 24h. The suspension was filtered and washed with cold pentane (-20°C) and dried in vacuo to give 1.7 g of a brown solid.
LCMS (-) ESI (relative abundance): 899.4 (22%, [M+TfO] ), 750.5 (6%, [M] ), 149.2 (100%, [OTf] ).
[NO3]- f-Pe-Mn-salen: Crude [NO3]- f-Pe-Mn-salen (2.07g) was suspended in heptane (14 mL) and heated to reflux for 1 h45 before being filtered hot. The cake was then washed with hot heptane, collected and dried in vacuo to give 1 .25 g of a brown solid.
LCMS (-) ESI (relative abundance): 1326.2 (10%, [2M] ), 725.4 (22%, [M+NO3] ), 663.2 (100%, [M] ).
Example 6: Epoxidation reactions using various catalysts: The epoxidation of (E)-[3-farnesene was performed as described in WO2022268840 producing a crude mixture containing (E)-[3--farnesene and (E)-[3-farnesene epoxides (Comp. II and III) which was then filtered through a pad of silica and Kugelrohr-distilled (120°C, 0.033 mbar). * qNMR purities of distilled mixture
The tested catalysts provide good results. It can be seen that the catalyst with terf-pentyl (f-Pe) residues on the phenyl rings allows for lower catalyst loading, while the yield and the selectivity towards the compound of formula (III) is improved. The further ligand Y improves the handling of the catalyst.

Claims

Claims
1. A method for making a compound of Formula (II), a compound of Formula (III) or a mixture thereof,
Formula (II) Formula (III) wherein the method comprises contacting a compound of Formula (IV) Formula (IV) with a catalyst comprising a metal M complexed with a salen ligand of formula (I) wherein each R1 is independently hydrogen, an alkyl group, an aryl group, or both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R2 is independently hydrogen or an alkyl group, or both R2 together with the carbon atoms to which R2 are attached form a cycloalkylene group or an arylene group; R3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group; m is selected from 0 to 4.
2. The method according to claim 1 , wherein the metal M is selected from the group consisting of Mn and V.
3. The method according to claim 2, wherein the metal M is further complexed with a ligand Y selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide.
4. The method according to any one of the previous claims, wherein R1, R2 and R3 is hydrogen.
5. The method according to any one of the previous claims, wherein m is 0.
6. The method according to claim 1 , wherein R1, R2 and R3 is hydrogen; m is 0; M is Mn; and wherein the metal M is further complexed with a ligand Y selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide, preferably acetate.
7. The method according to any one of the previous claims, comprising the making of the catalyst comprising a metal M complexed with a salen ligand of formula (I) wherein the making of the catalyst comprising a metal M complexed with a salen ligand of formula (I) comprises the steps of: a) mixing the salen ligand of formula (I) with a metal salt in a solvent, b) treating said mixture with an oxidant (preferable H2O2, oxygen, air, NaOCI, t- BuOOH), and c) optionally adding a salt to introduce the further ligand Y.
8. A method for making a compound of Formula (II), a compound of Formula (III) or a mixture thereof,
Formula (II) Formula (III) wherein the method comprises contacting a compound of Formula (IV) Formula (IV) with a catalyst of formula (X) comprising a metal M complexed with a salen ligand
Formula (X) wherein each R1 is independently hydrogen, an alkyl group, an aryl group, or both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R2 is independently hydrogen or an alkyl group, or both R2 together with the carbon atoms to which R2 are attached form a cycloalkylene group or an arylene group; R3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group;
R4 is selected from tert-butyl and tert-pentyl; m is selected from 0 to 4; the metal M is selected from the group consisting of Mn and V; and
Y is selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide.
9. The method according to claim 8 comprising the making of a catalyst of formula (X) comprising a metal M complexed with a salen ligand
Formula (X), wherein the making of the catalyst of formula (X) comprises a metal M complexed with a salen ligand comprises the steps of: a) mixing the salen ligand with a metal salt in a solvent, b) treating said mixture with an oxidant (preferable H2O2, oxygen, air, NaOCI, t- BuOOH), and c) optionally adding a salt to introduce the further ligand Y.
10. The method according to any one of the previous claims, wherein the catalyst is employed in about 0.01 - 0.6 mol% catalyst loading, preferably about 0.05 - 0.5 mol%, preferably about 0.1 - 0.4 mol%, for example 0.3 mol% catalyst loading.
11. A method of making compounds of Formula B and/or Amberketal, the method comprising the step of for making a compound of Formula (II), a compound of Formula (III) or a mixture thereof,
Formula (II) Formula (III) according to any one of the previous claims.
12. A catalyst comprising a metal M complexed with a salen ligand of formula (I) wherein each R1 is independently hydrogen, an alkyl group, an aryl group, or both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R2 is independently hydrogen or an alkyl group, or both R2 together with the carbon atoms to which R2 are attached form a cycloalkylene group or an arylene group;
R3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group; m is selected from 0 to 4.
13. A method for making a catalyst comprising a metal M complexed with a salen ligand of formula (I) comprising the steps of: a) mixing the salen ligand of formula (I) with a metal salt in a solvent, b) treating said mixture with an oxidant (preferable H2O2, oxygen, air, NaOCI, t- BuOOH), and c) optionally adding a salt to introduce the further ligand Y.
14. A catalyst of formula (X) comprising a metal M complexed with a salen ligand
Formula (X) wherein each R1 is independently hydrogen, an alkyl group, an aryl group, or both R1 together with the carbon atoms to which R1 are attached form a cycloalkylene group, an arylene group, two or more cycloalkylene groups connected by a single bond or an alkyl group or two or more arylene groups connected by a single bond or an alkyl group, or a cycloalkylene and an arylene group connected by a single bond or an alkyl group; each R2 is independently hydrogen or an alkyl group, or both R2 together with the carbon atoms to which R2 are attached form a cycloalkylene group or an arylene group;
R3 is selected from hydrogen, an optionally substituted alkyl group, an optionally substituted aryl group, a hydroxyl, an amino group;
R4 is selected from tert-butyl and tert-pentyl; m is selected from 0 to 4; the metal M is selected from the group consisting of Mn and V; and
Y is selected from the group consisting of acetate, tetrafluoroborate, triflate, nitrate, bromide, hexafluorophosphate, perchlorate and alkoxide.
15. A method for making a catalyst of formula (X) comprising a metal M complexed with a salen ligand
Formula (X), comprising the steps of: a) mixing the salen ligand with a metal salt in a solvent, b) treating said mixture with an oxidant (preferable H2O2, oxygen, air, NaOCI, t- BuOOH), and c) optionally adding a salt to introduce the further ligand Y.
PCT/EP2025/068016 2024-06-27 2025-06-26 Process Pending WO2026003142A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2409304.9A GB202409304D0 (en) 2024-06-27 2024-06-27 Process
GB2409304.9 2024-06-27

Publications (1)

Publication Number Publication Date
WO2026003142A1 true WO2026003142A1 (en) 2026-01-02

Family

ID=92213485

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2025/068016 Pending WO2026003142A1 (en) 2024-06-27 2025-06-26 Process

Country Status (2)

Country Link
GB (1) GB202409304D0 (en)
WO (1) WO2026003142A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021209482A1 (en) 2020-04-15 2021-10-21 Givaudan Sa Enzyme-mediated process for making amberketal and amberketal homologues
WO2022268840A1 (en) 2021-06-23 2022-12-29 Givaudan Sa Process for making epoxide derivatives of farnesene and use thereof in further synthesis
WO2024023154A1 (en) 2022-07-27 2024-02-01 Givaudan Sa Process

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021209482A1 (en) 2020-04-15 2021-10-21 Givaudan Sa Enzyme-mediated process for making amberketal and amberketal homologues
WO2022268840A1 (en) 2021-06-23 2022-12-29 Givaudan Sa Process for making epoxide derivatives of farnesene and use thereof in further synthesis
WO2024023154A1 (en) 2022-07-27 2024-02-01 Givaudan Sa Process

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
GAQUERE ANNE ET AL: "The readily available tert-pentyl group as a most effective simple directing group for asymmetric synthesis: a case study on Salen-Mn(III)-catalyzed epoxidation", TETRAHEDRON ASYMMETRY, vol. 13, no. 19, 1 January 2002 (2002-01-01), OXFORD, GB, pages 2089 - 2093, XP093294941, ISSN: 0957-4166, DOI: 10.1016/S0957-4166 (02)00582-7 *
GARCIA ANA M ET AL: "Encapsulation of SALEN- and SALHD-Mn(III) complexes in an Al-pillared clay for bicarbonate-assisted catalytic epoxidation of cyclohexene", JOURNAL OF MOLECULAR CATALYSIS A CHEMICAL, vol. 416, 11 February 2016 (2016-02-11), pages 10 - 19, XP029462470, ISSN: 1381-1169, DOI: 10.1016/J.MOLCATA.2016.01.034 *
INORGANICA CHIMICA ACTA, vol. 359, 2006, pages 197 - 203
JOURNAL OF ORGANIC CHEMISTRY, vol. 67, no. 28973-99-1, 2002, pages 2702 - 2704
LIANG SIDNEY ET AL: "A chiral salen vanadyl complex with two significantly different configurations in solid state: synthesis, characterization, and molecular structure", POLYHEDRON, vol. 21, no. 20, 1 September 2002 (2002-09-01), AMSTERDAM, NL, pages 2021 - 2025, XP093302537, ISSN: 0277-5387, Retrieved from the Internet <URL:https://pdf.sciencedirectassets.com/271375/1-s2.0-S0277538700X03853/1-s2.0-S0277538702011348/main.pdf?hash=2e0e318fdc39acea3186203f53c1b3f7d0e0afda0363032362d9449930d1d6d3&host=68042c943591013ac2b2430a89b270f6af2c76d8dfd086a07176afe7c76c2c61&pii=S0277538702011348&tid=spdf-bcf54272-c220-4d24-8cbd-8ef> DOI: 10.1016/S0277-5387(02)01134-8 *
ORGANIC LETTERS, vol. 24, no. 38, 2022, pages 6968 - 6972
OYAIZU KENICHI ET AL: "Crystal structures of dimeric manganese(III) complexes of tetradentate Schiff-base ligands with ancillary axial donors", INORGANICA CHIMICA ACTA, vol. 305, no. 2, 1 July 2000 (2000-07-01), NL, pages 184 - 188, XP093303107, ISSN: 0020-1693, Retrieved from the Internet <URL:https://pdf.sciencedirectassets.com/271401/1-s2.0-S0020169300X01156/1-s2.0-S0020169300001353/main.pdf?hash=3aa06fbf67190f0dee194ec5bf62104f16c5ca098bbe918a3798ee588c6b1363&host=68042c943591013ac2b2430a89b270f6af2c76d8dfd086a07176afe7c76c2c61&pii=S0020169300001353&tid=spdf-5d2239fd-26f0-45c8-afed-50d> DOI: 10.1016/S0020-1693(00)00135-3 *
S�BASTIEN RICHETER ET AL: "Syntheses, Crystal Structures, and Magnetic Properties of MnIII(L)phosphinate Complexes (L = meso-tetraphenylporphyrin or Schiff base)", EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, WILEY-VCH VERLAG , WENHEIM, DE, vol. 2013, no. 18, 10 May 2013 (2013-05-10), pages 3206 - 3216, XP072126312, ISSN: 1434-1948, DOI: 10.1002/EJIC.201300246 *
SUN HUI ET AL: "(Salen)Mn(III)-Catalyzed Enantioselective Intramolecular Haloamination of Alkenes through Chiral Aziridinium Ion Ring-Opening Sequence", ACS CATALYSIS, vol. 12, no. 12, 17 June 2022 (2022-06-17), US, pages 7046 - 7053, XP093020818, ISSN: 2155-5435, DOI: 10.1021/acscatal.2c02223 *

Also Published As

Publication number Publication date
GB202409304D0 (en) 2024-08-14

Similar Documents

Publication Publication Date Title
Chang et al. Effect of chiral quaternary ammonium salts on (salen) Mn-catalyzed epoxidation of cis-olefins. A highly enantioselective, catalytic route to trans-epoxides
Tam et al. Synthesis and electrophile-induced disproportionation of the neutral formyl triphenylphosphinenitrosyl-. eta.-cyclopentadienylrhenium formyl ((. eta.-C5H5) Re (NO)(PPh3)(CHO))
EP0817765B1 (en) Stereoselective ring opening reactions
EP2476688B1 (en) Ruthenium-based catalytic complexes and the use of such complexes for olefin metathesis
JPH01186829A (en) Production of tricyclo-8, 2, 2, 2-hexadeca-4, 6, 10, 12, 13, 15-hexaene chlorinated in benzene ring
CN114989063A (en) Synthesis method of beta-halopyrrole compound
CN114181191B (en) Synthesis method of cyclic sulfate
EP4359393A1 (en) Process for making epoxide derivatives of farnesene and use thereof in further synthesis
US7153806B2 (en) Encapsulated oxo-bridged organometallic cluster catalyst and a process for the preparation thereof
JP2022511915A (en) A method for directly constructing a highly optically active tetrasubstituted allene carboxylic acid compound
US6350916B1 (en) Selective oxidation of alcohols to aldehydes or ketones
CN101208346A (en) Conversion of Amorpha-4,11-diene to Artemisinin and Artemisinin Precursors
CN114989050B (en) Synthesis method of symmetric disulfide compounds
KR20080111035A (en) Ligand, its production method, and catalyst using the ligand
US4652692A (en) New process for the preparation of 1,3,5-undecatrienes
US5763623A (en) Process for catalytic epoxidation of olefinic compounds, novel cyclic ketone catalysts useful in said process
CN119462512B (en) Bisimidazole ligand, synthesis method thereof, metal catalyst prepared from bisimidazole ligand and application of metal catalyst
US6339157B1 (en) Synthesis of carboxamides from the catalyzed reaction of aldehydes and amines
WO2024034666A1 (en) Ruthenium complex, method for producing same, catalyst composition, oxidation method and method for producing oxygen-containing compound
JP2004261715A (en) Catalyst for regioselective oxidation of adamantane using porphyrin metal complex having imidazolyl group and method for regioselective oxidation of adamantane using the same
CN119798062A (en) A method for the iron-catalyzed quinone hydroxylation of olefins
Nishiuchi et al. Reactivity and efficient recycling of a chiral Pd-BINAP catalyst for catalytic asymmetric Diels-Alder reaction in ionic liquid
JPS6033375B2 (en) Method for producing 1,4-diacyloxybutene-2
CN119176819A (en) Method for preparing 3, 6-dihydro-1, 2-oxazine derivative by iodine catalysis in aqueous phase
CN118652235A (en) A kind of synthesis method of cyclohexene aldehyde compound and its application

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 25737168

Country of ref document: EP

Kind code of ref document: A1